Ixaka is a private UK-based cell and gene therapy company with operations in the UK, Spain and France. The company is focused on the natural power of the body to cure disease. Our proprietary technologies enhance the inherent therapeutic power of cells by targeting curative cells to the site of di... Read more
View all
Fios Genomics
Edinburgh, United Kingdom
Flow Robotics
Copenhagen, Denmark
Akoya Biosciences
Series D • San Francisco, United States
BioAge
Series C • Richmond, United States
Sano Genetics
Series A • England, United Kingdom
Verve Therapeutics
Series B • Cambridge, United States
BenevolentAI
Private Equity • England, United Kingdom
Leapcure
Seed • Los Angeles, United States
Oxford BioMedica
England, United Kingdom
Horizon Discovery
Post IPO Equity • Waterbeach, United Kingdom
Qkine
Seed • Cambridge, United Kingdom
F2G
Private Equity • Manchester, United Kingdom